A Jewel of a Resource From the Emerald Isle - - BioPharm International

ADVERTISEMENT

A Jewel of a Resource From the Emerald Isle

BioPharm International

The creation, dissemination, and exploitation of knowledge are the keys to unlocking the potential of Ireland's economy. Expertiseireland.com is a comprehensive research portal that provides a fast and effective gateway to the island's knowledge base. The portal offers a mechanism for identifying current research locations and support institutions for commercial and social capitalization. It presents in one searchable database up-to-date information on:



  • 3,900+ industry experts: research interests, projects, publications, conference history, patents, and consultancy background
  • Funding: viable funding sources on a local, national, and European level.
  • Technology transfer: innovative ideas produced in the third level sector available for capitalization

For added convenience, the portal also provides email alerts, which are triggered by changes to targeted expert profiles or funding opportunities, and current news that highlights issues relevant to R&D, education, finance, and capital investments.

Expertiseireland.com is directly populated from knowledge management systems originating at Ireland's academic institutions. The portal is designed primarily to help identify industry expertise and to serve as the contact point between those who create new ideas and those who implement them.

By providing a single access point, http://www.expertiseireland.com/ facilitates industry-academic collaborations and business-to-business alliances that utilize the world-class expertise and intellectual capital found on the island.

Expertiseireland.com is owned by the Irish Universities Association (Dublin, Ireland), formerly known as the Conference of Heads of Irish Universities. It is funded by InterTradeIreland. You may learn more about the association by visiting http://www.iua.ie/.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here